Open an account

Impact Biomedical

IBO · NYSE American

$3.27+$0.2075 (+6.78%)TodayMarket closed ·
Prev close $3.06

About IBO

Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2024-09-16. The company discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. The company has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. The company also evaluates additional technologies.

Employees
2
Headquarters
Houston, Texas
Listed
Sep 16, 2024
Sector
Health Care
Industry
Pharmaceuticals
Website
impactbiomedinc.com

IBO key statistics

Market cap
27.92M
Price-earnings ratio
0.28
Dividend yield
—
Average volume
15.73K
Volume
12.34K
Open price
$2.99
High today
$3.42
Low today
$2.67
52 Week high
$10.47
52 Week low
$2.43

Impact Biomedical (IBO) at a glance

As of Oct 20, 2026, Impact Biomedical (IBO) shares are priced at $3.27, giving the company a market cap of 27.92M and a price-to-earnings ratio of 0.28.

Today the stock has traded between $2.67 and $3.42. The current price is 22.2% above the day's low and 4.5% below its high.

Volume so far is 12.34K shares, below the average of 15.73K shares a day.

Over the past year Impact Biomedical has ranged from $2.43 to $10.47, and now sits 10% of the way up that range.

IBO news

  • Press releaseBusiness Wire

    Impact Biomedical Investor News: Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO

  • Press releaseBusiness Wire

    Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Avi Kapoor

    Crude Oil Surges 6%; BJ's Wholesale Club Earnings Top Views

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Similar companies

Companies in the same industry as Impact Biomedical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.